{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:40:50Z","timestamp":1792233650611,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004255","name":"Rajiv Gandhi University of Health Sciences","doi-asserted-by":"publisher","award":["24PHA282"],"award-info":[{"award-number":["24PHA282"]}],"id":[{"id":"10.13039\/501100004255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pharma.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:29:05Z","timestamp":1790836145000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro and In vivo evaluation of freeze-dried vaginal bigel of dolutegravir and lamivudine for HIV pre-exposure prophylaxis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4013-4316","authenticated-orcid":false,"given":"Sayani","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eswar Gupta","family":"Maddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.09.009_bib0145","unstructured":"Global HIV & AIDS statistics\u2014Fact sheet 2023. ReliefWeb. 2023. Available from: https:\/\/reliefweb.int\/report\/world\/global-hiv-aids-statistics-fact-sheet-2023. Accessed 2025 Jun 3."},{"key":"10.1016\/j.pharma.2026.09.009_bib0150","unstructured":"National Institutes of Health. What to start: initial combination antiretroviral regimens. ClinicalInfo HIV.gov. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/what-start-initial-combination. Accessed 2025 May 31."},{"key":"10.1016\/j.pharma.2026.09.009_bib0155","unstructured":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; n.d. Available at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586306\/, accessed on 2026 Feb 23."},{"key":"10.1016\/j.pharma.2026.09.009_bib0160","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1093\/jac\/dkaf345","article-title":"Effectiveness of first-line lamivudine\/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort","volume":"80","author":"Vergori","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharma.2026.09.009_bib0165","unstructured":"Dolutegravir-lamivudine oral: uses, side effects, interactions, pictures, warnings & dosing. WebMD. Available at: https:\/\/www.webmd.com\/drugs\/2\/drug-177074\/dolutegravir-lamivudine-oral\/details. Accessed 2026 March 31."},{"key":"10.1016\/j.pharma.2026.09.009_bib0170","first-page":"255","article-title":"Dolutegravir and lamivudine combination for the treatment of HIV-1 infection","volume":"11","author":"Zamora","year":"2019","journal-title":"HIV AIDS (Auckl)"},{"issue":"5","key":"10.1016\/j.pharma.2026.09.009_bib0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2026.09.009_bib0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","article-title":"On-demand microbicide products: design matters","volume":"7","author":"Patel","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.pharma.2026.09.009_bib0185","unstructured":"CAPRISA studies. CAPRISA. Available from: ht tps:\/\/w ww.caprisa.org\/Pages\/CAPRISAStudies. Accessed 2024 Jun 6."},{"issue":"6","key":"10.1016\/j.pharma.2026.09.009_bib0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1208\/s12249-025-03166-9","article-title":"Formulation development and characterization of bigels containing curcumin for topical skin delivery","volume":"26","author":"Liston","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2026.09.009_bib0195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.drudis.2021.12.011","article-title":"Bigels as drug delivery systems: from their components to their applications","volume":"27","author":"Mart\u00edn-Illana","year":"2022","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.pharma.2026.09.009_bib0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pharmaceutics11050232","article-title":"Smart freeze-dried bigels for the prevention of the sexual transmission of HIV by accelerating the vaginal release of tenofovir during intercourse","volume":"11","author":"Mart\u00edn-Illana","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharma.2026.09.009_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/gels8010015","article-title":"Enzyme-responsive vaginal microbicide gels containing maraviroc and tenofovir microspheres designed for acid phosphatase-triggered release for pre-exposure prophylaxis of HIV-1: a comparative analysis of a bigel and thermosensitive gel","volume":"8","author":"Ekama","year":"2022","journal-title":"Gels"},{"issue":"6","key":"10.1016\/j.pharma.2026.09.009_bib0210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/pharmaceutics17060784","article-title":"Hydroxypropyl methylcellulose\u2014a key excipient in pharmaceutical drug delivery systems","volume":"17","author":"Vlad","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2026.09.009_bib0215","series-title":"Biomaterial-based hydrogels: therapeutics carrier and tissue regeneration","first-page":"67","article-title":"Gelatin-based hydrogels for drug delivery: a recent update","author":"Kapoor","year":"2024"},{"key":"10.1016\/j.pharma.2026.09.009_bib0220","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/gels10120770","article-title":"3D printed bigel: a novel delivery system for cannabidiol-rich hemp extract","volume":"10","author":"Karpi","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.pharma.2026.09.009_bib0225","unstructured":"Rastogi R, Su J, Mahalingam A, Clark J, Sung S, Hope TJ, Kiser PF. Dosages for ARV drugs. In: Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. NCBI Bookshelf. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572728\/. Accessed 2026 Jan 9."},{"issue":"6","key":"10.1016\/j.pharma.2026.09.009_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/gels9060469","article-title":"Rheological considerations of pharmaceutical formulations: focus on viscoelasticity","volume":"9","author":"Budai","year":"2023","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.pharma.2026.09.009_bib0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/scipharm92010010","article-title":"Mucoadhesive vaginal tablets containing metronidazole: screening of optimal natural polymer in the composition","volume":"92","author":"Barton\u00edkov\u00e1","year":"2024","journal-title":"Sci Pharm"},{"key":"10.1016\/j.pharma.2026.09.009_bib0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biologic fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolution Technol"},{"issue":"4","key":"10.1016\/j.pharma.2026.09.009_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2015.11.008","article-title":"Engineering and characterization of simplified vaginal and seminal fluid simulants","volume":"93","author":"Rastogi","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.pharma.2026.09.009_bib0250","doi-asserted-by":"crossref","first-page":"125065","DOI":"10.1016\/j.ijpharm.2024.125065","article-title":"Bigels based on polyelectrolyte complexes as vaginal drug delivery systems","volume":"669","author":"Cazorla-Luna","year":"2025","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2026.09.009_bib0255","first-page":"74","article-title":"Experimental design supported liposomal aztreonam delivery: in vitro studies","volume":"11","author":"Bhattacharyya","year":"2020","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.pharma.2026.09.009_bib0260","first-page":"101747","article-title":"Evaluation of the antiviral activity of new dermaseptin analogs against Zika virus","volume":"39","author":"Haddad","year":"2024","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.pharma.2026.09.009_bib0265","doi-asserted-by":"crossref","first-page":"128816","DOI":"10.1016\/j.ijbiomac.2023.128816","article-title":"Pre-exposure prophylactic mucoadhesive sodium alginate microsphere laden pessaries for intravaginal delivery of tenofovir disoproxil fumarate","volume":"258","author":"Avlani","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2026.09.009_bib0270","unstructured":"Highlights of prescribing information. U.S. Food and Drug Administration; 2021. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/pepfar\/210787PI.pdf, Accessed on 2026 Jan 31."},{"issue":"3","key":"10.1016\/j.pharma.2026.09.009_bib0275","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11483-020-09633-z","article-title":"Influence of soya lecithin, sorbitan and glyceryl monostearate on physicochemical properties of organogels","volume":"15","author":"Ghan","year":"2020","journal-title":"Food Biophys"},{"issue":"3","key":"10.1016\/j.pharma.2026.09.009_bib0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/scipharm93030028","article-title":"Development and characterization of bigels for the topical delivery of curcumin","volume":"93","author":"P\u00e9rez-Salas","year":"2025","journal-title":"Sci Pharm"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926001483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926001483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:40:42Z","timestamp":1792230042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926001483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S0003450926001483"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.09.009","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and In vivo evaluation of freeze-dried vaginal bigel of dolutegravir and lamivudine for HIV pre-exposure prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}